Generate Biomedicines, Inc. (GENB)

NASDAQ: GENB · Real-Time Price · USD

12.83

+0.30 (2.44%)

Oct 15, 2026, 1:18 PM EDT - Market open

Generate Biomedicines Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	1,646	-	-
Market Cap Growth	-	-	-
Enterprise Value	1,251	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	0.14	0.36	0.22
Net Debt / Equity Ratio	-0.87	-0.81	-0.89
Net Debt / EBITDA Ratio	1.58	0.69	1.74
Net Debt / FCF Ratio	1.62	0.75	2.61
Asset Turnover	-	0.08	-
Quick Ratio	8.08	2.70	4.55
Current Ratio	8.30	2.85	4.70
Return on Equity (ROE)	-	-81.72%	-
Return on Assets (ROA)	-	-34.63%	-
Return on Capital Employed (ROCE)	-52.00%	-94.80%	-45.60%

Yields

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Buyback Yield / Dilution	-	-2.77%	-

SEC Filings: 10-K · 10-Q